Research programme: propiconazole derivative nanoparticle - Astellas PharmaAlternative Names: MXP-4509
Latest Information Update: 16 Jul 2016
At a glance
- Originator Unknown
- Class Triazoles
- Mechanism of Action 14-alpha demethylase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Candidiasis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Candidiasis in Romania
- 12 Sep 2012 Early research in Candidiasis in Romania (unspecified route)